← Back to Search

Ceragenin Coated Endotracheal Tube

CeraShield Endotracheal Tube for Intubation

N/A
Waitlist Available
Research Sponsored by N8 Medical, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days post enrollment or hospital discharge, whichever comes first
Awards & highlights

Summary

Single-arm, feasibility study to evaluate the Ceragenin Coated Endotracheal Tube (the CeraShield ETT) in adults who require intubation and are expected to be mechanically ventilated for ≥ 24 hours.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days post enrollment or hospital discharge, whichever comes first
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days post enrollment or hospital discharge, whichever comes first for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of Adverse Events
Secondary study objectives
Positive ETT colonization
Positive QEA

Trial Design

1Treatment groups
Experimental Treatment
Group I: CeraShield Endotracheal TubeExperimental Treatment1 Intervention
Subjects who are expected to require mechanical ventilation for 24 hours or longer will be intubated with the CeraShield ETT.

Find a Location

Who is running the clinical trial?

N8 Medical, LLCLead Sponsor
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top